Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled Rahal

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Pathology|March 22, 2025
Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?Imen Zawati, Yousra Troujette, Olfa Adouni, et al.
Journal of Orthopaedics|January 1, 2016
Triple locations of elastofibroma dorsi: First case report and reviewJamel B Hassouna, Bassem Mezghani, Bouthaina Laamouri, et al.
Breast Disease|March 6, 2018
Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancerSyrine Abdeljaoued, Lhem Bettaieb, Meher Nasri, et al.
La Tunisie Medicale|October 4, 2017
Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic indexOlfa El Amine, Rihem Ouni, Olfa Adouni, et al.
La Tunisie Medicale|June 13, 2017
Mucinous breast carcinoma a rare entity to be known: clinico-pathological study of 48 casesOlfa El Amine El Hadj, Malek Ayadi, Aida Goucha, et al.
La Tunisie Medicale|February 1, 2007
[Hydatid cyst of ovary. Report of 7 cases]Ridha Makhlouf, Amor Gamoudi, Tarek Bouzid, et al.
La Tunisie Medicale|July 8, 2017
Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic indexOlfa El Amine, Rihem Ouni, Olfa Adouni, et al.
La Tunisie Medicale|June 2, 2016
Ki-67: role in diagnosis, prognosis and follow-up after treatment of breast cancersHouda El Benna, Aref Zribi, Soumaya Laabidi, et al.
Oncology Research and Treatment|April 5, 2017
Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast CancerSyrine Abdeljaoued, Ilhem Bettaieb, Meher Nasri, et al.
The Pan African Medical Journal|September 28, 2019
Coexistence of invasive ductal breast carcinoma and fibroadenomaFatma Saadallah, Imen Bouraoui, Lamia Naija, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Pathology|March 22, 2025
Can residual proliferative cancer burden predict long-term outcomes following neoadjuvant chemotherapy in breast cancer?Imen Zawati, Yousra Troujette, Olfa Adouni, et al.
Journal of Orthopaedics|January 1, 2016
Triple locations of elastofibroma dorsi: First case report and reviewJamel B Hassouna, Bassem Mezghani, Bouthaina Laamouri, et al.
Breast Disease|March 6, 2018
Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancerSyrine Abdeljaoued, Lhem Bettaieb, Meher Nasri, et al.
La Tunisie Medicale|October 4, 2017
Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic indexOlfa El Amine, Rihem Ouni, Olfa Adouni, et al.
La Tunisie Medicale|June 13, 2017
Mucinous breast carcinoma a rare entity to be known: clinico-pathological study of 48 casesOlfa El Amine El Hadj, Malek Ayadi, Aida Goucha, et al.
La Tunisie Medicale|February 1, 2007
[Hydatid cyst of ovary. Report of 7 cases]Ridha Makhlouf, Amor Gamoudi, Tarek Bouzid, et al.
La Tunisie Medicale|July 8, 2017
Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic indexOlfa El Amine, Rihem Ouni, Olfa Adouni, et al.
La Tunisie Medicale|June 2, 2016
Ki-67: role in diagnosis, prognosis and follow-up after treatment of breast cancersHouda El Benna, Aref Zribi, Soumaya Laabidi, et al.
Oncology Research and Treatment|April 5, 2017
Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast CancerSyrine Abdeljaoued, Ilhem Bettaieb, Meher Nasri, et al.
The Pan African Medical Journal|September 28, 2019
Coexistence of invasive ductal breast carcinoma and fibroadenomaFatma Saadallah, Imen Bouraoui, Lamia Naija, et al.
Pageof 9